Actively Recruiting

Age: 18Years +
All Genders
ID06271291

Pancreatic Cancer Detection Consortium Prospective Cohorts to Study High-Risk Individuals Without Pancreatic Cancer

Led by Mayo Clinic · Updated on 2026-06-01

30000

Participants Needed

9

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Mayo Clinic

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying individuals who do not have pancreatic cancer but are considered at higher-than-average lifetime risk of developing it. This observational study aims to create a group of participants with strong family histories, specific genetic mutations, or high-risk pancreatic cysts to better detect pancreatic or other cancers early when treatment may be more effective. The study is sponsored by the Mayo Clinic and focuses on collecting data and biospecimens to help identify biomarkers for pancreatic cancer risk. Participants will undergo blood sample collection, complete questionnaires, and have their medical records reviewed. Those with pancreatic cysts may also have cyst fluid collected during standard endoscopic ultrasound fine needle aspiration procedures. This process allows the study team to gather important biological samples and clinical information without additional invasive procedures beyond usual care. During the study, participants will be followed over time with repeated biospecimen collection and medical record reviews to track health outcomes. The researchers will develop a biobank of samples and data at enrollment and continue collecting information throughout the study period, which runs until November 2029. This ongoing follow-up helps monitor changes and supports research to validate early detection methods for pancreatic cancer.

CONDITIONS

Brief Title

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years or older
  • For family history or genetic mutation group: age 50 or older plus specific family history or genetic mutation criteria related to pancreatic cancer
  • For pancreatic cyst group: age 18 or older with pancreatic cysts meeting Fukuoka worrisome or high-risk criteria
  • Ability to provide informed consent
  • Willingness to participate in blood sampling, questionnaires, and medical record review
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • History of non-autologous bone marrow transplant or active blood cancer such as leukemia or lymphoma
  • Current or prior diagnosis of pancreatic cancer or total pancreatectomy
  • Current incarceration as a prison inmate
  • Inability to speak or read English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surveillance

Duration - Up to study completion (approximately 6 years)

Participants who undergo routine care are observed with blood sample collection, questionnaires, medical record reviews, and pancreatic cyst fluid collection during standard of care procedures.

Visits occur during routine endoscopic ultrasound procedures as needed

Trial Site Locations

Total: 9 locations

1

HonorHealth Research Institute

Scottsdale, Arizona, United States, 85258

Withdrawn

2

Piedmont Healthcare

Atlanta, Georgia, United States, 30309

Actively Recruiting

3

OSF Saint Francis Medical Center

Peoria, Illinois, United States, 61615

Actively Recruiting

4

The Johns Hopkins University School of Medicine

Baltimore, Maryland, United States, 21231

Actively Recruiting

5

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02215

Actively Recruiting

6

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905

Actively Recruiting

7

University of Nebraska Medical Center

Omaha, Nebraska, United States, 68198-6805

Actively Recruiting

8

Oregon Health & Science University

Portland, Oregon, United States, 97201

Actively Recruiting

9

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15232

Actively Recruiting

Loading map...

Research Team

C

Clinical Trials Referral Office

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

HERTHENA-PanTumor01: A Phase 2, Multicenter, Open-Label Stud...

Advanced Solid Tumor

Actively Recruiting

85 locations

A Phase 1, First-in-Human, Open Label, Dose Escalation and C...

Advanced Solid Tumors

Actively Recruiting

7 locations

Exploratory Clinical Trial to Assess Safety, Tolerability, E...

Pancreatic Carcinoma

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here